Pharma channel feed – Endpoints News

Pharma channel feed

FDA simplifies Covid-19 bivalent vaccination process ahead of June adcomm

3 years ago

J&J sales near $25B for Q1, with solid oncology, immunology gains

3 years ago

Consumer trust in pharma industry holds steady amid economic, inequality uneasiness — Edelman survey

3 years ago

MarketingRx roundup: Eisai partners on head and neck cancer campaign; AstraZeneca, Daiichi ads pop up at AACR

3 years ago

Cancers caused by HPV are still on the rise, even as awareness of the connection is dropping: #AACR23

3 years ago

FDA inspection at Lupin manufacturing site uncovers breakdowns left uninvestigated and data questions

3 years ago

Eli Lilly invests another $1.6B into Indiana manufacturing sites

3 years ago

Apellis raises uncommon eye disease profile with ‘The Fonz’ actor Henry Winkler

3 years ago

Moderna debuts corporate ad campaign 'telling the story of mRNA’ across its ambitions

3 years ago

Moderna and Merck prepare for PhIII trial of cancer vaccine, and an expansion to lung cancer: #AACR23

3 years ago

Years before $43B Pfizer deal, a mystery company made six proposals for Seagen

3 years ago

Supreme Court steps in to stay Texas court's ruling on mifepristone

3 years ago

Novartis inks deal to help manufacture J&J and Legend's Carvykti

3 years ago

AstraZeneca’s rare disease group Alexion debuts first-ever TV ad

3 years ago

FDA rejects Lilly's ulcerative colitis drug mirikizumab over manufacturing issues

3 years ago

Novo Nordisk increases 2023 sales, profit outlook as semaglutide sales boom

3 years ago

Novavax trims $50M in costs but did not reduce headcount, CEO says

3 years ago

Biotech and cancer center researchers star in Stand Up To Cancer’s latest commercial

3 years ago

Pfizer teams up with Sinopharm to market 12 new drugs in China — report

3 years ago

GSK argues against taking Teva 'skinny' label suit to SCOTUS

3 years ago

At $2M per shot, ICER says two new sickle cell gene therapies could be cost-effective

3 years ago

Ahead of adcomm, FDA backs Rexulti for first approval for agitation associated with Alzheimer’s dementia

3 years ago

Outcome Health executives convicted in $1B pharma advertising and investing fraud scheme

3 years ago

Biotech execs say mifepristone decision would 'upend' FDA's new drug application process

3 years ago

First page Previous page 128 129 130131132 133 134 Next page Last page